FDA Approves Stem Cell Study for Spinal Injuries

The Food and Drug Administration approved the first clinical trial today that will use human embryonic stem cells to potentially draw recent paraplegics out of the wheelchair and back on their feet. Scientists hope the stem cell therapy will prevent permanent paralysis caused by acute spinal cord injuries and even return feeling and movement in patients who suffered the paralyzing injury two weeks before treatment. The treatment showed positive results when tested in rats. "In animal models,...Full Story
Commenting on this article is closed.